May 8, 2025 - 09:37
Enerflex Ltd. has unveiled its financial and operational results for the first quarter of 2025, showcasing impressive figures that reflect the company's robust performance. The company achieved an adjusted EBITDA of $113 million, alongside a substantial free cash flow of $85 million. These results are indicative of Enerflex's strong operational capabilities and market positioning.
The company also reported a significant contract backlog, totaling $1.5 billion, which provides a solid foundation for future revenue generation. Additionally, the engineering services backlog stands at $1.2 billion, further enhancing operational visibility and growth prospects for the upcoming quarters.
Furthermore, Enerflex successfully reduced its bank-adjusted net debt-to-EBITDA ratio to 1.3x at the end of the first quarter, highlighting its commitment to maintaining a healthy balance sheet. These results underscore Enerflex's strategic focus on operational efficiency and financial stability, positioning the company for continued success in the competitive energy sector.
August 15, 2025 - 23:28
Americans Express Growing Concerns About Their Financial HealthA recent survey reveals that a significant portion of the American population is feeling increasingly uneasy about their financial circumstances. According to the latest findings from a poll, one...
August 15, 2025 - 01:59
Financial Mismanagement Exposed: NC Auditor Report on WS/FCSIn a comprehensive 39-page report, the Office of the State Auditor has uncovered significant financial mismanagement within the Winston-Salem/Forsyth County Schools (WS/FCS), highlighting issues...
August 14, 2025 - 19:34
Trust Issues in the Car Finance Sector: A Call for ReformThe recent car finance scandal has highlighted the ongoing trust issues between lenders and borrowers in the financial sector. As more consumers seek loans to purchase vehicles, the integrity of...
August 14, 2025 - 08:18
Financial Update: Progress in CMT-SORD Treatment InitiativesIn a notable advancement for the treatment of Charcot-Marie-Tooth disease with sorbitol accumulation (CMT-SORD), a company has reported significant developments in its ongoing initiatives. A...